Schmaljohn C - Search Results

1

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.

Vanderzanden L, Bray M, Fuller D, Roberts T, Custer D, Spik K, Jahrling P, Huggins J, Schmaljohn A, Schmaljohn C. Vanderzanden L, et al. Among authors: schmaljohn a, schmaljohn c. Virology. 1998 Jun 20;246(1):134-44. doi: 10.1006/viro.1998.9176. Virology. 1998. PMID: 9657001 Free article.

2

Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.

Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM. Schmaljohn CS, et al. Among authors: schmaljohn al. J Virol. 1990 Jul;64(7):3162-70. doi: 10.1128/JVI.64.7.3162-3170.1990. J Virol. 1990. PMID: 1972201 Free PMC article.

3

Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies.

Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS. Arikawa J, et al. Among authors: schmaljohn cs, schmaljohn al. J Gen Virol. 1989 Mar;70 ( Pt 3):615-24. doi: 10.1099/0022-1317-70-3-615. J Gen Virol. 1989. PMID: 2471792

4

Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins.

Schmaljohn CS, Parker MD, Ennis WH, Dalrymple JM, Collett MS, Suzich JA, Schmaljohn AL. Schmaljohn CS, et al. Among authors: schmaljohn al. Virology. 1989 May;170(1):184-92. doi: 10.1016/0042-6822(89)90365-6. Virology. 1989. PMID: 2655274

5

Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus.

Wang M, Pennock DG, Spik KW, Schmaljohn CS. Wang M, et al. Among authors: schmaljohn cs. Virology. 1993 Dec;197(2):757-66. doi: 10.1006/viro.1993.1652. Virology. 1993. PMID: 7504368

6

DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection.

Hooper JW, Kamrud KI, Elgh F, Custer D, Schmaljohn CS. Hooper JW, et al. Among authors: schmaljohn cs. Virology. 1999 Mar 15;255(2):269-78. doi: 10.1006/viro.1998.9586. Virology. 1999. PMID: 10069952 Free article.

7

Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine.

McClain DJ, Summers PL, Harrison SA, Schmaljohn AL, Schmaljohn CS. McClain DJ, et al. Among authors: schmaljohn cs, schmaljohn al. J Med Virol. 2000 Jan;60(1):77-85. doi: 10.1002/(sici)1096-9071(200001)60:1<77::aid-jmv13>3.0.co;2-s. J Med Virol. 2000. PMID: 10568767 Clinical Trial.

8

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.

Hooper JW, Custer DM, Schmaljohn CS, Schmaljohn AL. Hooper JW, et al. Among authors: schmaljohn cs, schmaljohn al. Virology. 2000 Jan 20;266(2):329-39. doi: 10.1006/viro.1999.0096. Virology. 2000. PMID: 10639319 Free article.

9

DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

Hooper JW, Custer DM, Thompson E, Schmaljohn CS. Hooper JW, et al. Among authors: schmaljohn cs. J Virol. 2001 Sep;75(18):8469-77. doi: 10.1128/jvi.75.18.8469-8477.2001. J Virol. 2001. PMID: 11507192 Free PMC article.

10

Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.

Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW. Custer DM, et al. Among authors: schmaljohn cs. J Virol. 2003 Sep;77(18):9894-905. doi: 10.1128/jvi.77.18.9894-9905.2003. J Virol. 2003. PMID: 12941899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters